Skip to content
Rare Disease Tracker
Most Favored Nation Tracker
Rare Disease Tracker
Most Favored Nation Tracker
Methodology
All entries for: Rege Nephro Co.
March 26, 2026
Rege Nephro Co.
Orphan Drug Designation
treatment of autosomal dominant polycystic kidney disease
Disease Area:
Rare Disease
Source
Scroll to Top
